Food and Drug Administration
Peripheral and Central Nervous System Drugs Advisory Committee
November 18, 2002
Briefing Information
Issues Related to the Role of Brain Imaging as an Outcome Measure in Phase III Trials of Putative Drugs for Alzheimer's Disease (HTM) (PDF) (Word)